{"title":"Hypertension in Thailand.","authors":"Sirirat Leelacharas","doi":"10.1111/j.1751-7117.2009.00059.x","DOIUrl":"https://doi.org/10.1111/j.1751-7117.2009.00059.x","url":null,"abstract":"Thailand is located in Southeast Asia, with a population of more than 63 million people, approximately 6 million living in the capital Bangkok. Health problems increase with an increase in the population and the subsequent increase in the population density. For decades, the national health care system of Thailand has been developing along with the National Social and Economic Development Plans of the country (from the first plan to the ninth plan). At present, the 10th Thai National Health Care Plan, covering the years 2007 to 2011, is being followed. Included in the Plan are efforts to decrease the morbidity and mortality rate of Thai people due to hypertension, a very significant health problem. In the past, free Thai health care was only provided to individuals and families who worked in governmental organizations or public enterprises. Eventually, in 2002, Thailand enacted a law that provided national health care for all Thai citizens. This law gave the Thai people the opportunity to receive free health care for prevention and treatment, especially related to hypertension. Hypertension is a major contributing factor for cardiovascular disease, stroke, and renal disease, which occur in most countries in the world including Thailand. In fact, hypertension is one of the leading risk factors for cardiovascular diseases and death in Thailand. Thai people are often not aware of the fact that they have hypertension because hypertensive symptoms are not clearly evident to them. Moreover, many Thai people do not know how to prevent hypertension. Some patients find out that they have hypertension on their visit to physicians with stroke manifestations. Changes in the lifestyle behaviors of Thai people, such as dietary patterns and physical activities that may be associated with the development of hypertension, have occurred due to changes in the social and economic development of the country. This paper reviews the definitions and the prevalence rate of pre-hypertension and hypertension; changes in Thais’ lifestyle behavior; percentages of awareness, treatment, and hypertension control; and nurses’ roles in health promotion and risk reduction relative to hypertension.","PeriodicalId":77333,"journal":{"name":"Progress in cardiovascular nursing","volume":"24 4","pages":"196-8"},"PeriodicalIF":0.0,"publicationDate":"2009-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1751-7117.2009.00059.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28587458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Sepsis and cardiac disease: improving outcomes through recognition and management.","authors":"Martie Mattson","doi":"10.1111/j.1751-7117.2009.00060.x","DOIUrl":"https://doi.org/10.1111/j.1751-7117.2009.00060.x","url":null,"abstract":"","PeriodicalId":77333,"journal":{"name":"Progress in cardiovascular nursing","volume":"24 4","pages":"199-201"},"PeriodicalIF":0.0,"publicationDate":"2009-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1751-7117.2009.00060.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28587459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"What is the significance of T-wave inversion in the precordial leads?","authors":"Angela Tsiperfal, Kimberly Scheibly","doi":"10.1111/j.1751-7117.2009.00061.x","DOIUrl":"https://doi.org/10.1111/j.1751-7117.2009.00061.x","url":null,"abstract":"Patient N was vacationing in the Las Vegas and winning at the blackjack table when he noticed a sudden onset of rapid heart rate and passed out. When EMTs arrived, patient was found to be in wide complex tachycardia at the rate of 140 to 160 bpm. Patient was defibrillated x1 and converted to sinus rhythm. Mr N is a healthy 36-year-old businessman without any significant medical history. He is not taking any prescription or over the counter medications. His review of systems and physical exam are unremarkable. His family history is significant for an older brother who died suddenly at the age of 35. His younger sister has been having episodes of frequent unexplained syncope but has not been evaluated yet. His subsequent evaluation included electrocardiography (ECG), laboratory studies, echocardiogram, cardiac catheterization, electrophysiology study, and cardiac MRI. The ECG in sinus rhythm showed precordial ST elevations, T-wave inversions, and epsilon waves. Echocardiogram showed normal LV and RV size and systolic function with estimated EF 60%. There were no signs of coronary artery disease on cardiac cath. The EP study was positive for inducible VT that was mapped to the RV free wall. Cardiac MRI showed marked thinning of the right ventricular myocardium and ‘‘fatty infiltration’’ in the right ventricular free wall. Patient was diagnosed with arrhythmogenic right ventricular cardiomyopathy (ARVC) and the ICD was implanted and b-blocker therapy was initiated. Genetic testing was done, results pending.","PeriodicalId":77333,"journal":{"name":"Progress in cardiovascular nursing","volume":"24 4","pages":"202-3"},"PeriodicalIF":0.0,"publicationDate":"2009-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1751-7117.2009.00061.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28587460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Melanie K Bean, Douglas Gibson, Maureen Flattery, Angela Duncan, Michael Hess
{"title":"Psychosocial factors, quality of life, and psychological distress: ethnic differences in patients with heart failure.","authors":"Melanie K Bean, Douglas Gibson, Maureen Flattery, Angela Duncan, Michael Hess","doi":"10.1111/j.1751-7117.2009.00051.x","DOIUrl":"https://doi.org/10.1111/j.1751-7117.2009.00051.x","url":null,"abstract":"Advances in treatment have prolonged life in heart failure (HF) patients, leading to increased attention to quality of life (QOL) and psychological functioning. It is not clear if ethnic differences exist in factors associated with psychological well-being. We examined psychosocial factors associated with depression and anxiety in 97 HF patients. Medical records were reviewed and patients (M age 53, 50% African American) completed surveys examining social support, coping, spirituality, and QOL for their association with depression and anxiety. Multiple regressions suggested that psychosocial factors were associated with psychological health. Patients with lower social support, lower meaning/peace and more negative coping reported greater depression; positive coping, and lower meaning/peace were associated with higher anxiety. Ethnicity stratified models suggested that spiritual well-being was associated with depression only among African Americans and QOL partially mediated this relationship. Findings suggest the importance of considering the unique psychosocial needs of diverse populations to appropriately target clinical interventions.","PeriodicalId":77333,"journal":{"name":"Progress in cardiovascular nursing","volume":"24 4","pages":"131-40"},"PeriodicalIF":0.0,"publicationDate":"2009-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1751-7117.2009.00051.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28587497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Atrial septal defect devices used in the cardiac catheterization laboratory.","authors":"Lisa Gervasi, Sharna Basu","doi":"10.1111/j.1751-7117.2009.00040.x","DOIUrl":"https://doi.org/10.1111/j.1751-7117.2009.00040.x","url":null,"abstract":"<p><p>An atrial septal defect (ASD) is a hole in the atrium of the heart. There are 3 types of ASDs; sinus venosus (high in the atrial septum), secundum ASD (middle of septum), and ostium primum (low in the septum). The most common ASD is a secundum ASD. Secundum ASDs are caused by a failure of the atrial septum to close completely during the development of the heart. The most common reported symptoms are fatigue and shortness of breath. Most patients are found to have an ASD after evaluation for a murmur. All ASDs used to be repaired by open heart surgery. However, with advances in the cardiac catheterization lab and development of new devices, some secundum ASDs are able to be closed in the catheterization lab by an interventional cardiologist. There are various types of devices that may be used for closure of an ASD in the cardiac catheterization laboratory. This paper will address 2 of the devices most commonly used. Anticoagulation therapy will need to be followed for approximately 6 months and echocardiograms will need to be obtained at follow-up visits. Nurses have an important role in preparing and teaching the patient and family about the ASD closure procedure and follow-up care.</p>","PeriodicalId":77333,"journal":{"name":"Progress in cardiovascular nursing","volume":"24 3","pages":"86-9"},"PeriodicalIF":0.0,"publicationDate":"2009-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1751-7117.2009.00040.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28389214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Chronic angina and the treatment with ranolazine: facts and recommendations.","authors":"Heather Carrier Milne, April Hazard Vallerand","doi":"10.1111/j.1751-7117.2009.00041.x","DOIUrl":"https://doi.org/10.1111/j.1751-7117.2009.00041.x","url":null,"abstract":"<p><p>More than 6 million people in the United States are affected by chronic angina. On January 27, 2006, the US Food and Drug Administration (FDA) approved a new medication for the treatment of chronic stable angina called ranolazine (Ranexa). This is the first angina drug approved by the FDA in over a decade. The unique thing about this drug is that it falls into a new class of therapies in that it works at the level of cellular metabolism in decreasing demand on the cardiac tissue. There are many factors to consider when prescribing this medication including past studies, dosing, and education. There is also evidence that this drug may also benefit diabetic patients with glycemic control.</p>","PeriodicalId":77333,"journal":{"name":"Progress in cardiovascular nursing","volume":"24 3","pages":"90-5"},"PeriodicalIF":0.0,"publicationDate":"2009-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1751-7117.2009.00041.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28389215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jennifer Wayment Allen, Cynthia Arslanian-Engoren, Judith Lynch-Sauer
{"title":"The lived experience of middle-aged women with New York Heart Association class III heart failure: a pilot study.","authors":"Jennifer Wayment Allen, Cynthia Arslanian-Engoren, Judith Lynch-Sauer","doi":"10.1111/j.1751-7117.2009.00042.x","DOIUrl":"https://doi.org/10.1111/j.1751-7117.2009.00042.x","url":null,"abstract":"<p><p>Although heart failure (HF) is equally prevalent in men and women, women with HF are more likely to report decreased quality of life and are more likely to die of the disease compared with men. Moreover, HF has been studied less extensively in women and no study has specifically addressed women with New York Heart Association (NYHA) class III HF using a qualitative method. This pilot study sought to gain insight into the lived experience of women with NYHA class III HF. Using a phenomenological approach, interviews obtained from 4 middle-aged women with NYHA class III HF were analyzed using the Giorgi method of data analysis. Five themes emerged: (1) developing a new conception of self, (2) conceding physical limitations, (3) enduring emotional heartache, (4) accepting support, and (5) rejuvenating through rest. This study provides a beginning to our understanding of the lived experience of women with NYHA class III HF. However, further exploration is needed to increase our knowledge of HF in women, particularly among diverse populations.</p>","PeriodicalId":77333,"journal":{"name":"Progress in cardiovascular nursing","volume":"24 3","pages":"96-101"},"PeriodicalIF":0.0,"publicationDate":"2009-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1751-7117.2009.00042.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28389216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lorraine Frazier, Shu-Fen Wung, Elizabeth Sparks, Cathy Eastwood
{"title":"Cardiovascular nursing on human genomics: what do cardiovascular nurses need to know about congestive heart failure?","authors":"Lorraine Frazier, Shu-Fen Wung, Elizabeth Sparks, Cathy Eastwood","doi":"10.1111/j.1751-7117.2009.00039.x","DOIUrl":"https://doi.org/10.1111/j.1751-7117.2009.00039.x","url":null,"abstract":"<p><p>This paper presents the main causes of heart failure (HF) and an update on the genetics studies on each cause. The review includes a delineation of the etiology and fundamental pathophysiology of HF and provides rational for treatment for the patient and family. Various cardiomyopathies are discussed, including primary cardiomyopathies, mixed cardiomyopathies, cardiomyopathies that involve altered cardiac muscle along with generalized multiorgan disorders, and various cardiovascular conditions, such as coronary artery disease (ischemic cardiomyopathy) and hypertension (hypertensive cardiomyopathy). A brief review of pharmacogenetics and HF is presented. The application of the genetic components of cardiomyopathy and pharmacogenetics is included to enhance cardiovascular nursing care.</p>","PeriodicalId":77333,"journal":{"name":"Progress in cardiovascular nursing","volume":"24 3","pages":"80-5"},"PeriodicalIF":0.0,"publicationDate":"2009-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1751-7117.2009.00039.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28389213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The systematic development of a nursing intervention aimed at increasing enrollment in cardiac rehabilitation for acute coronary syndrome patients.","authors":"Sylvie Cossette, Louis-Xavier D'Aoust, Magali Morin, Sonia Heppell, Nancy Frasure-Smith","doi":"10.1111/j.1751-7117.2009.00038.x","DOIUrl":"https://doi.org/10.1111/j.1751-7117.2009.00038.x","url":null,"abstract":"<p><p>Acute coronary syndrome (ACS) is a leading cause of morbidity worldwide. Although cardiac rehabilitation (CR) programs can decrease recurrence of coronary events by as much as 25%, few patients engage in CR after a cardiac event. Current therapeutic procedures for ACS are provided quickly after the onset of symptoms, resulting in briefer hospital stays. Therefore, within this shorter time frame, the education of patients about ACS risk factors and their reduction presents a new nursing challenge. The purpose of this paper is to describe the systematic pathway in the development of a nursing intervention which addresses these new challenges in ACS risk factor reduction. The intervention aims to increase enrollment in CR, and enhance illness perceptions and medication adherence, while decreasing anxiety, risk factors, and emergency revisits.</p>","PeriodicalId":77333,"journal":{"name":"Progress in cardiovascular nursing","volume":"24 3","pages":"71-9"},"PeriodicalIF":0.0,"publicationDate":"2009-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1751-7117.2009.00038.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28387011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}